Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1971 Apr;114(4):19–30.

The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.

C R Kleeman, S G Massry, J W Coburn
PMCID: PMC1501857  PMID: 4927915

Full text

PDF
19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer W., Albright F., Aub J. C. A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY II. J Clin Invest. 1930 Feb;8(2):229–248. doi: 10.1172/JCI100262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Better O. S., Garty J., Brautbar N., Barzilai D. Diminished functional parathyroid reserve following I-131 treatment for hyperthyroidism. Isr J Med Sci. 1969 May-Jun;5(3):419–422. [PubMed] [Google Scholar]
  3. Black W. C., 3rd, Utley J. R. The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol. 1968 Jun;49(6):761–775. doi: 10.1093/ajcp/49.6.761. [DOI] [PubMed] [Google Scholar]
  4. Bronsky D., Kiamko R. T., Waldstein S. S. Familial idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 1968 Jan;28(1):61–65. doi: 10.1210/jcem-28-1-61. [DOI] [PubMed] [Google Scholar]
  5. DENT C. E., FRIEDMAN M. A COMPARISON BETWEEN A.T. 10 AND PURE DIHYDROTACHYSTEROL IN CONTROLLING HYPOPARATHYROIDISM. Lancet. 1964 Jul 25;2(7352):164–169. doi: 10.1016/s0140-6736(64)90229-6. [DOI] [PubMed] [Google Scholar]
  6. Gittes R. F., Toverud S. U., Cooper C. W. Effects of hypercalcemia and hypocalcemia on the thyrocalcitonin content of rat thyroid glands. Endocrinology. 1968 Jan;82(1):83–90. doi: 10.1210/endo-82-1-83. [DOI] [PubMed] [Google Scholar]
  7. Haas H. G. Metabolic criteria for primary hyperparathyroidism. Helv Med Acta. 1966 Jun;33(2):91–107. [PubMed] [Google Scholar]
  8. Harrison H. E., Lifshitz F., Blizzard R. M. Comparison between crystalline dihydrotachysterol and calciferol in patients requiring pharmacologic vitamin D therapy. N Engl J Med. 1967 Apr 20;276(16):894–900. doi: 10.1056/NEJM196704202761603. [DOI] [PubMed] [Google Scholar]
  9. Ireland A. W., Clubb J. S., Neale F. C., Posen S., Reeve T. S. The calciferol requirements of patients with surgical hypoparathyroidism. Ann Intern Med. 1968 Jul;69(1):81–89. doi: 10.7326/0003-4819-69-1-81. [DOI] [PubMed] [Google Scholar]
  10. Johnston C. I., Martin T. J., Riddell J. Medullary thyroid carcinoma: a functional peptidesecreting tumour. Australas Ann Med. 1970 Feb;19(1):50–53. doi: 10.1111/imj.1970.19.1.50. [DOI] [PubMed] [Google Scholar]
  11. Kalu D. N., Doyle F. H., Pennock J., Foster G. V. Parathyroid hormone and experimental osteosclerosis. Lancet. 1970 Jun 27;1(7661):1363–1366. doi: 10.1016/s0140-6736(70)91271-7. [DOI] [PubMed] [Google Scholar]
  12. Kaye M., Chatterjee G., Cohen G. F. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis. Ann Intern Med. 1970 Aug;73(2):225–233. doi: 10.7326/0003-4819-73-2-225. [DOI] [PubMed] [Google Scholar]
  13. Koppel M. H., Massry S. G., Shinaberger J. H., Hartenbower D. L., Coburn J. W. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med. 1970 Jun;72(6):895–901. doi: 10.7326/0003-4819-72-6-895. [DOI] [PubMed] [Google Scholar]
  14. Lee J. B., Tashjian A. H., Jr, Streeto J. M., Frantz A. G. Familial pseudohypoparathyroidism. Role of parathyroid hormone and thyrocalcitonin. N Engl J Med. 1968 Nov 28;279(22):1179–1184. doi: 10.1056/NEJM196811282792201. [DOI] [PubMed] [Google Scholar]
  15. Lloyd H. M. Primary hyperparathyroidism: an analysis of the role of the parathyroid tumor. Medicine (Baltimore) 1968 Jan;47(1):53–71. [PubMed] [Google Scholar]
  16. Marks S. C., Jr The parafollicular cell of the thyroid gland as the source of an osteoblast-stimulating factor. Evidence from experimentally osteopetrotic mice. J Bone Joint Surg Am. 1969 Jul;51(5):875–890. [PubMed] [Google Scholar]
  17. Marks S. C., Jr, Walker D. G. The role of the parafollicular cell of the thyroid gland in the pathogenesis of congenital osteopetrosis in mice. Am J Anat. 1969 Nov;126(3):299–313. doi: 10.1002/aja.1001260305. [DOI] [PubMed] [Google Scholar]
  18. Martin T. J., Melick R. A. The acute effects of porcine calcitonin in man. Australas Ann Med. 1969 Aug;18(3):258–263. doi: 10.1111/imj.1969.18.3.258. [DOI] [PubMed] [Google Scholar]
  19. Melick R. A., Baird C. W. Changes in plasma calcium after injection of calcium in hypothyroid and hypoparathyroid women. J Clin Endocrinol Metab. 1967 Sep;27(9):1303–1308. doi: 10.1210/jcem-27-9-1303. [DOI] [PubMed] [Google Scholar]
  20. Melvin K. E., Tashjian A. H., Jr The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1216–1222. doi: 10.1073/pnas.59.4.1216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Milhaud G., Moukhtar M. S., Bourichon J., Perault A. M. Existence et activité de la thyrocalcitonine chez l'homme. C R Acad Sci Hebd Seances Acad Sci D. 1965 Nov 22;261(21):4513–4516. [PubMed] [Google Scholar]
  22. Munson P. L., Tashjian A. H., Jr, Levine L. Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res. 1965 Aug;25(7):1062–1067. [PubMed] [Google Scholar]
  23. Nathaniels E. K., Nathaniels A. M., Wang C. A. Mediastinal parathyroid tumors: a clinical and pathological study of 84 cases. Ann Surg. 1970 Feb;171(2):165–170. doi: 10.1097/00000658-197002000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nichols G., Jr, Flanagan B. Normocalcemic hyperparathyroidism. Trans Assoc Am Physicians. 1967;80:314–322. [PubMed] [Google Scholar]
  25. Pak C. Y., DeLuca H. F., Chavez de los Rios J. M., Suda T., Ruskin B., Delea C. S. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol. Arch Intern Med. 1970 Aug;126(2):239–247. [PubMed] [Google Scholar]
  26. Parfitt A. M. Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med. 1969 Jul 10;281(2):55–59. doi: 10.1056/NEJM196907102810201. [DOI] [PubMed] [Google Scholar]
  27. Popovtzer M. M., Schainuck L. I., Massry S. G., Kleeman C. R. Divalent ion excretion in chronic kidney disease: relation to degree of renal insufficiency. Clin Sci. 1970 Mar;38(3):297–307. doi: 10.1042/cs0380297. [DOI] [PubMed] [Google Scholar]
  28. Reiss E., Canterbury J. M. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med. 1969 Jun 19;280(25):1381–1385. doi: 10.1056/NEJM196906192802504. [DOI] [PubMed] [Google Scholar]
  29. Reitz R. E., Pollard J. J., Wang C. A., Fleischli D. J., Cope O., Murray T. M., Deftos L. J., Potts J. T., Jr Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay. N Engl J Med. 1969 Aug 14;281(7):348–351. doi: 10.1056/NEJM196908142810704. [DOI] [PubMed] [Google Scholar]
  30. Sherwood L. M., O'Riordan J. L., Aurbach G. D., Potts J. T., Jr Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab. 1967 Jan;27(1):140–146. doi: 10.1210/jcem-27-1-140. [DOI] [PubMed] [Google Scholar]
  31. Smith R. N., Laljee H. C. Thyrocalcitonin deficiency after treatment of thyroid disorders by surgery or radioiodine. Br Med J. 1967 Dec 9;4(5579):589–591. doi: 10.1136/bmj.4.5579.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Suh S. M., Kooh S. W., Chan A. M., Fraser D., Tashjian A. H., Jr Pseudohypoparathyroidism: no improvement following total thyroidectomy. J Clin Endocrinol Metab. 1969 Apr;29(4):429–439. doi: 10.1210/jcem-29-4-429. [DOI] [PubMed] [Google Scholar]
  33. Tashjian A. H., Jr, Frantz A. G., Lee J. B. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142. doi: 10.1073/pnas.56.4.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Williams E. D., Brown C. L., Doniach I. Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol. 1966 Mar;19(2):103–113. doi: 10.1136/jcp.19.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. YAMAHIRO H. S., REYNOLDS T. B. Phosphate excretion in normal and hyperparathyroid subjects with controlled phosphate intake. Metabolism. 1962 Feb;11:213–225. [PubMed] [Google Scholar]
  36. Yendt E. R., Gagne R. J. Detection of primary hyperparathyroidism, with special reference to its occurrence in hypercalciuric females with "normal" or borderline serum calcium. Can Med Assoc J. 1968 Feb 17;98(7):331–336. [PMC free article] [PubMed] [Google Scholar]
  37. Yendt E. R., Gagné R. J., Cohanim M. The effects of thiazides in idiopathic hypercalciuria. Am J Med Sci. 1966 Apr;251(4):449–460. doi: 10.1097/00000441-196604000-00009. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES